[Featured Stock] NanoEntek Rises on News of Rights Offering Increase
NanoEntek is showing strong performance.
As of 9:06 AM on the 14th, NanoEntek is trading on the KOSDAQ market at 4,035 KRW, up 790 KRW (24.35%) from the previous day.
On the same day, NanoEntek announced that it will conduct a third-party paid-in capital increase worth 17.5 billion KRW targeting Aplus Asset Advisors.
The company is a manufacturer and seller of point-of-care testing (POCT) medical devices and biotechnology research equipment based on lab-on-a-chip technology.
It has formed partnerships with Thermo Fisher Scientific and PerkinElmer in the United States to supply biotechnology research equipment products through contract manufacturing.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- "Hancom Breaks Away from Its 36-Year Mission and Formula for Success" (Comprehensive)
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
In 2023, the in vitro diagnostics division launched the ADAM-rWBC HT (high-throughput automated white blood cell counter) based on proven technology, expanding coverage in U.S. blood banks and entering the European market.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
